1. Home
  2. OKTA vs ALGN Comparison

OKTA vs ALGN Comparison

Compare OKTA & ALGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Okta Inc.

OKTA

Okta Inc.

HOLD

Current Price

$80.15

Market Cap

15.0B

Sector

Technology

ML Signal

HOLD

Logo Align Technology Inc.

ALGN

Align Technology Inc.

HOLD

Current Price

$175.91

Market Cap

12.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OKTA
ALGN
Founded
2009
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Industrial Specialties
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.0B
12.0B
IPO Year
2017
2000

Fundamental Metrics

Financial Performance
Metric
OKTA
ALGN
Price
$80.15
$175.91
Analyst Decision
Buy
Buy
Analyst Count
37
11
Target Price
$111.37
$192.40
AVG Volume (30 Days)
3.1M
1.2M
Earning Date
06-01-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
102.76
0.53
EPS
0.96
5.65
Revenue
$2,610,000,000.00
$387,126,000.00
Revenue This Year
$10.83
$5.85
Revenue Next Year
$9.40
$4.52
P/E Ratio
$74.95
$32.28
Revenue Growth
15.33
23.95
52 Week Low
$68.77
$122.00
52 Week High
$127.52
$208.31

Technical Indicators

Market Signals
Indicator
OKTA
ALGN
Relative Strength Index (RSI) 49.64 44.35
Support Level $77.03 $170.63
Resistance Level $91.71 $186.51
Average True Range (ATR) 4.13 5.84
MACD 0.03 -1.89
Stochastic Oscillator 56.30 11.01

Price Performance

Historical Comparison
OKTA
ALGN

About OKTA Okta Inc.

Okta is a cloud-native security company that focuses on identity and access management. The San Francisco-based firm went public in 2017 and focuses on two key client stakeholder groups: workforces and customers. Okta's workforce offerings enable a company's employees to securely access its cloud-based and on-premises resources. The firm's customer offerings allow its clients' customers to securely access the client's applications.

About ALGN Align Technology Inc.

Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.

Share on Social Networks: